Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nature Wood Group ADR | NWGL | Nov 13, 2024 | 1.51 | 0.00 |
Natures Miracle Holding | NMHI | Nov 13, 2024 | 0.14 | +65.69 |
Natures Sunshine Products | NATR | Nov 13, 2024 | 15.96 | -2.83 |
Natuzzi ADR | NTZ | Nov 13, 2024 | 4.05 | 0.00 |
NatWest ADR | NWG | Nov 13, 2024 | 9.96 | -0.20 |
Nauticus Robotics | KITT | Nov 13, 2024 | 1.14 | -12.69 |
Nautilus Biotechnology | NAUT | Nov 13, 2024 | 2.47 | -0.80 |
Navidea Biopharmaceuticals | NAVB | Nov 13, 2024 | 0.00 | 0.00 |
Navient | NAVI | Nov 13, 2024 | 15.26 | -1.55 |
Navigator Holdings | NVGS | Nov 13, 2024 | 15.87 | +1.67 |
Navios Maritime Partners LP Unit | NMM | Nov 13, 2024 | 49.93 | +2.17 |
Navitas Semiconductor | NVTS | Nov 13, 2024 | 1.79 | -4.79 |
Naya Biosciences | NAYA | Nov 13, 2024 | 0.84 | 0.00 |
Nayax | NYAX | Nov 13, 2024 | 28.00 | +6.75 |
NB Bancorp | NBBK | Nov 13, 2024 | 20.52 | -0.82 |
NBT Bancorp | NBTB | Nov 13, 2024 | 50.32 | -0.42 |
Ncino | NCNO | Nov 13, 2024 | 41.49 | -1.98 |
NCR | VYX | Nov 13, 2024 | 14.60 | +2.67 |
NCR Atleos When Issued | NATL | Nov 13, 2024 | 30.42 | +4.75 |
NCS Multistage | NCSM | Nov 13, 2024 | 23.32 | -0.09 |
Nebius Group | NBIS | Nov 13, 2024 | 18.57 | 0.00 |
Nektar Therapeutics | NKTR | Nov 13, 2024 | 1.28 | -2.29 |
Nelnet | NNI | Nov 13, 2024 | 110.37 | +1.01 |
Neogen | NEOG | Nov 13, 2024 | 15.18 | -1.04 |
NeoGenomics | NEO | Nov 13, 2024 | 16.43 | +0.61 |
Neonode | NEON | Nov 13, 2024 | 5.90 | -8.24 |
NeoVolta | NEOV | Nov 13, 2024 | 5.11 | -4.13 |
Nephros | NEPH | Nov 13, 2024 | 1.63 | -0.61 |
NerdWallet A | NRDS | Nov 13, 2024 | 15.32 | +2.20 |
Nerdy A | NRDY | Nov 13, 2024 | 0.82 | -8.97 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.